Skip to main content
. 2022 Feb 2;44(2):750–763. doi: 10.3390/cimb44020052

Table 5.

Variants detected in oncogenes/tumor-suppressor genes in all sequenced CTCs within a subject that were shared by ≥2 NSCLC patients.

Gene Number of Variants
TP53 4
NF1 2
SMARCB1 1
SMAD4 1
PTEN 1
PTCH1 1
MAP2K1 1
KRAS 1
JAK3 1
ERBB2 1
DNMT3A 1
CTNNB1 1
ABL1 1
ALK 1